Racial Disparity in Postpartum Readmission due to Hypertension among Women with Pregnancy-Associated Hypertension

Rebecca Chornock; Sara N. Iqbal; Tetsuya Kawakita

doi:10.1055/s-0040-1712530

American Journal of Perinatology, Table of Contents

Am J Perinatol 2021; 38(12): 1297-1302
DOI: 10.1055/s-0040-1712530

Original Article

Racial Disparity in Postpartum Readmission due to Hypertension among Women with Pregnancy-Associated Hypertension

Rebecca Chornock

¹Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, District of Columbia

,

Sara N. Iqbal

¹Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, District of Columbia

,

Tetsuya Kawakita

¹Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, District of Columbia

› Author Affiliations

Abstract

Objective Postpartum hypertension is a leading cause of readmission in the postpartum period. We aimed to examine the prevalence of racial/ethnic differences in postpartum readmission due to hypertension in women with antepartum pregnancy-associated hypertension.

Study Design This was a multi-institutional retrospective cohort study of all women with antepartum pregnancy-associated hypertension diagnosed prior to initial discharge from January 2009 to December 2016. Antepartum pregnancy-associated hypertension, such as gestational hypertension, preeclampsia (with or without severe features), hemolysis, elevated liver enzyme, low platelet (HELLP) syndrome, and eclampsia was diagnosed based on American College of Obstetricians and Gynecologists Task Force definitions. Women with chronic hypertension and superimposed preeclampsia were excluded. Our primary outcome was postpartum readmission defined as a readmission due to severe hypertension within 6 weeks of postpartum. Risk factors including maternal age, gestational age at admission, insurance, race/ethnicity (self-reported), type of antepartum pregnancy-associated hypertension, marital status, body mass index (kg/m²), diabetes (gestational or pregestational), use of antihypertensive medications, mode of delivery, and postpartum day 1 systolic blood pressure levels were examined. Multivariable logistic regression models were performed to calculate adjusted odds ratios (aORs) and 95% confidence intervals (95% CIs).

Results Of 4,317 women with pregnancy-associated hypertension before initial discharge, 66 (1.5%) had postpartum readmission due to hypertension. Risk factors associated with postpartum readmission due to hypertension included older maternal age (aOR = 1.44; 95% CI: 1.20–1.73 for every 5 year increase) and non-Hispanic black race (aOR = 2.12; 95% CI: 1.16–3.87).

Conclusion In women with pregnancy-associated hypertension before initial discharge, non-Hispanic black women were at increased odds of postpartum readmission due to hypertension compared with non-Hispanic white women.

Keywords

postpartum - preeclampsia - readmission

Full Text

References

References
1 Clapp MA, Little SE, Zheng J, Robinson JN. A multi-state analysis of postpartum readmissions in the United States. Am J Obstet Gynecol 2016; 215 (01) 113.e1-113.e10
2 Gynecologists ACO, Pregnancy TFH. ; American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. report of the American College of Obstetricians and Gynecologists' Task Force on hypertension in pregnancy. Obstet Gynecol 2013; 122 (05) 1122-1131
3 Mogos MF, Salemi JL, Spooner KK, McFarlin BL, Salihu HH. Hypertensive disorders of pregnancy and postpartum readmission in the United States: national surveillance of the revolving door. J Hypertens 2018; 36 (03) 608-618
4 Creanga AA, Syverson C, Seed K, Callaghan WM. Pregnancy-related mortality in the United States, 2011-2013. Obstet Gynecol 2017; 130 (02) 366-373
5 Tanaka M, Jaamaa G, Kaiser M. et al. Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study. Am J Public Health 2007; 97 (01) 163-170
6 Beckie TM. Ethnic and racial disparities in hypertension management among women. Semin Perinatol 2017; 41 (05) 278-286
7 Shahul S, Tung A, Minhaj M. et al. Racial disparities in comorbidities, complications, and maternal and fetal outcomes in women with preeclampsia/eclampsia. Hypertens Pregnancy 2015; 34 (04) 506-515
8 Aseltine Jr RH, Yan J, Fleischman S, Katz M, DeFrancesco M. Racial and ethnic disparities in hospital readmissions after delivery. Obstet Gynecol 2015; 126 (05) 1040-1047
9 Hirshberg A, Levine LD, Srinivas SK. Clinical factors associated with readmission for postpartum hypertension in women with pregnancy-related hypertension: a nested case control study. J Perinatol 2016; 36 (05) 405-409
10 Larsen WI, Strong JE, Farley JH. Risk factors for late postpartum preeclampsia. J Reprod Med 2012; 57 (1-2): 35-38
11 Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004; 103 (5, Pt 1): 981-991
12 Boggess KA, Tita A, Jauk V. et al; Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium. Risk factors for postcesarean maternal infection in a trial of extended-spectrum antibiotic prophylaxis. Obstet Gynecol 2017; 129 (03) 481-485
13 Jiang HJ, Andrews R, Stryer D, Friedman B. Racial/ethnic disparities in potentially preventable readmissions: the case of diabetes. Am J Public Health 2005; 95 (09) 1561-1567
14 Joynt KE, Orav EJ, Jha AK. Thirty-day readmission rates for Medicare beneficiaries by race and site of care. JAMA 2011; 305 (07) 675-681
15 Tan LK, de Swiet M. The management of postpartum hypertension. BJOG 2002; 109 (07) 733-736
16 Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol 2012; 206 (06) 470-475
17 Chobanian AV, Bakris GL, Black HR. et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289 (19) 2560-2572
18 Whelton PK, Carey RM, Aronow WS. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation 2018; 138 (17) e426-e483
19 Kovell LC, Ahmed HM, Misra S. et al. US Hypertension management guidelines: a review of the recent past and recommendations for the future. J Am Heart Assoc 2015; 4 (12) e002315
20 Ascarelli MH, Johnson V, McCreary H, Cushman J, May WL, Martin Jr JN. Postpartum preeclampsia management with furosemide: a randomized clinical trial. Obstet Gynecol 2005; 105 (01) 29-33
21 Viteri OA, Alrais MA, Pedroza C. et al. Torsemide for prevention of persistent postpartum hypertension in women with preeclampsia: a randomized controlled Trial. Obstet Gynecol 2018; 132 (05) 1185-1191
22 Al-Safi Z, Imudia AN, Filetti LC, Hobson DT, Bahado-Singh RO, Awonuga AO. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol 2011; 118 (05) 1102-1107
23 Thiel de Bocanegra H, Braughton M, Bradsberry M, Howell M, Logan J, Schwarz EB. Racial and ethnic disparities in postpartum care and contraception in California's Medicaid program. Am J Obstet Gynecol 2017; 217 (01) 47.e1-47.e7
24 James PA, Oparil S, Carter BL. et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311 (05) 507-520